Back to Results
First PageMeta Content
23andMe / Food and Drug Administration / Genetic testing / FDA Warning Letter / Genetics / Medicine / Biology


THE WALL STREET JOURNAL BUSINESS 23andMe CEO Responds to FDA Warning Letter Anne Wojcicki Defends Genetic Tests, Acknowledges Company Late in Responding to Agency Concerns
Add to Reading List

Document Date: 2014-10-31 19:01:19

Open Document

File Size: 1,61 MB

Share Result on Facebook

City

Boston / /

Company

23andMe Inc. / Facebook / Google Inc. / /

Currency

USD / /

/

Facility

Women's Hospital / /

IndustryTerm

television advertising campaign / genetic-test maker / /

MedicalCondition

Ehlers-Danlos syndrome / certain disease / both common and inherited diseases / disease / own disease / breast and ovarian cancer / inherited connective-tissue disorder / /

MedicalTreatment

surgery / breast-cancer surgery / /

Organization

Women's Hospital / Food and Drug Administration / American Society for Human Genetics / Obama administration / Harvard / FDA / /

Person

PETER LOFTUS / Diana Cleaveland / Anne Wojcicki / Robert Green / RON WINSLOW / /

Position

Chief Executive / genetics medicine researcher / WALL STREET JOURNAL BUSINESS 23andMe CEO Responds / genetic counselor / head / spokeswoman / /

SocialTag